Immuron (IMRN) Other Non-Current Assets (2018 - 2023)
Immuron (IMRN) recorded quarterly Other Non-Current Assets of $7846.9 in Q4 2023, down 99.35% quarter-over-quarter from $1.2 million in Q3 2023, and down 21.15% on a YoY basis from $9951.3 in Q4 2022.
Immuron (IMRN) Other Non-Current Assets (2018 - 2023) Analysis & Trends
Immuron's Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $7846.9 for Q4 2023.
- In Q4 2023, Other Non-Current Assets fell 21.15% year-over-year to $7846.9; the TTM figure through Dec 2023 stood at $7846.9 (down 21.15% YoY), while the FY2023 annual figure was $18340.3, up 84.3% from the prior year.
- Other Non-Current Assets was $7846.9 for Q4 2023 at Immuron, down from $1.2 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $17.8 million in Q2 2022 to a low of $7846.9 in Q4 2023.
- Historically, Other Non-Current Assets has averaged $2.7 million across 4 years, with a median of $573601.7 in 2023.
- The sharpest annual moves came in 2020 and 2023: Other Non-Current Assets retreated 13.45% in 2020, then tumbled 99.93% in 2023.
- A 4-year view of Other Non-Current Assets shows it stood at $1.3 million in 2019, then fell by 13.45% to $1.1 million in 2020, then sank by 99.12% to $9951.3 in 2022, then decreased by 21.15% to $7846.9 in 2023.
- The last three Other Non-Current Assets figures came in at $7846.9 (Q4 2023), $1.2 million (Q3 2023), and $18340.3 (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 7,846.88 |
| Sep 28, 2023 | 1.20 Mn |
| Aug 30, 2023 | 18,340.34 |
| Jun 30, 2023 | 12,257.96 |
| Dec 31, 2022 | 9,951.34 |
| Jun 30, 2022 | 17.81 Mn |
| Jun 30, 2020 | 1.13 Mn |
| Jun 30, 2019 | 1.30 Mn |
| Jun 30, 2018 | 1.64 Mn |